These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2655212)

  • 1. An increase in the survival of murine H-2-mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporine.
    Burkhardt K; Charlton B; Mandel TE
    Transplantation; 1989 May; 47(5):771-5. PubMed ID: 2655212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GK1.5 monoclonal antibody dosage on survival of pig proislet xenografts in CD4+ T cell-depleted mice.
    Simeonovic CJ; Ceredig R; Wilson JD
    Transplantation; 1990 May; 49(5):849-56. PubMed ID: 1970911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of hamster islet xenografts in mice under short-course treatment with nondepleting versus depleting anti-CD4 monoclonal antibodies.
    Lu X; Schulz M; Zihlmann HR; Borel JF
    Xenotransplantation; 1998 May; 5(2):154-63. PubMed ID: 9584829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic anti-CD4 monoclonal antibody secretion by mouse segmental pancreas allografts promotes long term survival.
    Mottram PL; Murray-Segal LJ; Han W; Zhan Y; Brady JL; Lew AM
    Transpl Immunol; 2000 Nov; 8(3):203-9. PubMed ID: 11147701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice.
    Akita K; Ogawa M; Mandel TE
    Cell Transplant; 1994; 3(1):61-73. PubMed ID: 7512875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal pancreas transplantation in non-obese diabetic (NOD) mice. A comparison of iso-, allo- and xenografts.
    Mandel TE; Koulmanda M; Bacelj A
    Horm Metab Res Suppl; 1990; 25():166-73. PubMed ID: 2088961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice.
    Mandel TE; Dillon H; Koulmanda M
    Transpl Immunol; 1995 Sep; 3(3):265-72. PubMed ID: 8581416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
    Yang TY; Sun Y; Langnas AN; Zhao Y
    Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells.
    Darby CR; Morris PJ; Wood KJ
    Transplantation; 1992 Sep; 54(3):483-90. PubMed ID: 1384184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice.
    Rashid A; Auchincloss H; Sharon J
    J Immunol; 1992 Mar; 148(5):1382-8. PubMed ID: 1538121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
    He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
    Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.
    Simeonovic CJ; Brown DJ; Townsend MJ; Wilson JD
    Cell Transplant; 1996; 5(5):525-41. PubMed ID: 8889212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation.
    Purcell LJ; Mottram PL; Mandel TE
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
    Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
    Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
    Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
    Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.